November 26, 2024 Cloud-enabled integrated diagnostics portfolio aims to unify workflows, improve access to critical insights, and drive better outcomes for patients Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a ...
Read MoreNovember 25, 2024 icometrix’ FDA-cleared quantitative brain solution for neurological conditions including Alzheimer’s and multiple sclerosis is seamlessly integrated into Philips next generation BlueSeal MR scanners, and will be deployed in its ...
Read MorePR Newswire NEW YORK, Nov. 29, 2024 NEW YORK, Nov. 29, 2024 /PRNewswire/ -- Report on how AI is driving market transformation - The global cannabis testing market size is estimated to grow by USD 2.05 billion from 2024-2028, according to ...
Read MoreCanada NewsWire OTTAWA, ON, Nov. 29, 2024 OTTAWA, ON, Nov. 29, 2024 /CNW/ - Breast cancer is one of the most common forms of cancer and the second leading cause of cancer-related death among women* living in Canada. One in eight women is ...
Read MorePR Newswire LEWES, Del., Nov. 29, 2024 The growth of the Urinalysis Test Market is primarily driven by the increasing prevalence of urinary tract infections (UTIs) and kidney diseases, necessitating regular screening and monitoring. ...
Read MorePR Newswire LEWES, Del., Nov. 29, 2024 The Static Compression Therapy Market is driven by the rising prevalence of chronic venous disorders, obesity, and post-surgical recovery needs. Increasing awareness of the benefits of compression ...
Read MorePR Newswire DENVER, Nov. 29, 2024 Imidex's Technology is a Front-End Patient Acquisition Tool for Healthcare Providers Targeting Early Lung Cancer Detection, Achieving 83% Sensitivity in Identifying Lung Nodules in Chest X-rays. DENVER, ...
Read MorePR Newswire SHANGHAI, Nov. 29, 2024 SHANGHAI, Nov. 29, 2024 /PRNewswire/ -- Recently, Shanghai MicuRx Pharmaceutical Co., Ltd. ("MicuRx", 688373.SH) announced the successful completion of its Phase III clinical trial of MRX-4 for injection ...
Read MorePR Newswire SHANGHAI, Nov. 29, 2024 SHANGHAI, Nov. 29, 2024 /PRNewswire/ -- Minghui Pharmaceutical, a late-stage biopharmaceutical company dedicated to developing transformative medicines in immunology and oncology, today announced positive ...
Read MorePR Newswire STOCKHOLM, Nov. 29, 2024 STOCKHOLM, Nov. 29, 2024 /PRNewswire/ -- RaySearch will be exhibiting its advanced software solutions at RSNA in Chicago, Illinois, December 1 – 4. RSNA is the largest conference show in the field of ...
Read MorePR Newswire HYDERABAD, India, Nov. 29, 2024 HYDERABAD, India, Nov. 29, 2024 /PRNewswire/ -- Bharath Advanced Therapeutics (BAT) and the Federation of Asian Biotech Associations (FABA) are proud to jointly present Cancer NEXT 2024, a premier ...
Read MorePR Newswire NEW YORK, Nov. 28, 2024 NEW YORK, Nov. 28, 2024 /PRNewswire/ -- Report on how AI is redefining market landscape - The global immunoassay market size is estimated to grow by USD 8.64 billion from 2024-2028, according to Technavio. ...
Read MorePR Newswire HOISINGTON, Kan., Nov. 28, 2024 Audra, a dedicated single mother of four, continues her courageous battle against cancer with unwavering strength and determination. Audra, whose name fittingly means 'Noble Strength,' embodies ...
Read MorePR Newswire REDDING, Calif., Nov. 28, 2024 REDDING, Calif., Nov. 28, 2024 /PRNewswire/ -- According to a new market research report titled, 'Vitamins Market Size, Share, Forecast, & Trends Analysis by Type (Vitamin A, Vitamin B, Vitamin C, ...
Read MorePR Newswire TAIPEI, Nov. 28, 2024 TAIPEI, Nov. 28, 2024 /PRNewswire/ -- Taiwan-based Formosa Pharmaceuticals ("Formosa", 6838.TW) announced that the company has entered into an exclusive licensing agreement with Medvisis Switzerland AG ...
Read MorePR Newswire SAN FRANCISCO and SUZHOU, China, Nov. 27, 2024 SAN FRANCISCO and SUZHOU, China, Nov. 27, 2024 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, ...
Read MorePR Newswire HONG KONG, Nov. 27, 2024 HONG KONG, Nov. 27, 2024 /PRNewswire/ -- Akeso, Inc. (9926. HK) ("Akeso" or the "Company") is pleased to announce that two of its independently developed, globally pioneering bispecific antibody ...
Read MorePR Newswire TOKYO and CAMBRIDGE, Mass., Nov. 27, 2024 TOKYO and CAMBRIDGE, Mass., Nov. 27, 2024 /PRNewswire/ -- Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: ...
Read MorePR Newswire ALBANY, N.Y., Nov. 27, 2024 ALBANY, N.Y., Nov. 27, 2024 /PRNewswire/ -- The Galactosemia Foundation, a non-profit charitable organization that advocates for people with Galactosemia and their families, issued the following ...
Read MorePR Newswire NEW YORK, Nov. 27, 2024 NEW YORK, Nov. 27, 2024 /PRNewswire/ -- Report on how AI is driving market transformation - The global microfluidics for healthcare application market size is estimated to grow by USD 110.2 billion from ...
Read MorePR Newswire LAS VEGAS, Nov. 27, 2024 An increase in research and development (R&D) activities in myotonic dystrophy is expected to drive market growth by enhancing the understanding of the disease, accelerating drug discovery, and creating ...
Read MorePR Newswire NEW YORK, Nov. 27, 2024 NEW YORK, Nov. 27, 2024 /PRNewswire/ -- Report with the AI impact on market trends - The global advanced wound care market size is estimated to grow by USD 4.19 billion from 2024-2028, according to ...
Read MorePR Newswire NEW YORK, Nov. 27, 2024 NEW YORK, Nov. 27, 2024 /PRNewswire/ -- Report on how AI is driving market transformation - The global biomaterials market size is estimated to grow by USD 12.76 billion from 2024-2028, according to ...
Read MoreCanada NewsWire RENFREW, ON, Nov. 27, 2024 RENFREW, ON, Nov. 27, 2024 /CNW/ - The overdose crisis is one of the most serious public health crises our country has ever faced. It is driven by a dangerous illegal synthetic drug supply that is ...
Read MoreCanada NewsWire OTTAWA, ON, Nov. 27, 2024 OTTAWA, ON, Nov. 27, 2024 /CNW/ - The Government of Canada is committed to addressing barriers to internal trade to facilitate trade, economic growth, and competitiveness for food businesses without ...
Read MorePR Newswire DARIEN, Conn., Nov. 27, 2024 DARIEN, Conn., Nov. 27, 2024 /PRNewswire/ -- For the first time, researchers have examined the safety and efficacy of migraine neuromodulation therapy across subtypes of migraine-associated most ...
Read MorePR Newswire LONDON, Nov. 27, 2024 LONDON, Nov. 27, 2024 /PRNewswire/ -- A landmark new Global State of Tobacco Harm Reduction (GSTHR) report uses the latest evidence and new data projections to assess the current global tobacco harm ...
Read MorePR Newswire TAIPEI, Nov. 27, 2024 Taiwanese Companies Address Critical Needs in Patient Care, Minimally Invasive Surgery, and Sustainable Practices TAIPEI, Nov. 27, 2024 /PRNewswire/ -- Several leading Taiwanese companies are at the ...
Read MorePR Newswire HOLLYWOOD, Fla., Nov. 27, 2024 Empowering patients and advancing gastric cancer awareness through expert insights and community support HOLLYWOOD, Fla., Nov. 27, 2024 /PRNewswire/ -- Debbie's Dream Foundation: Curing Stomach ...
Read MorePR Newswire BUSAN, South Korea, Nov. 27, 2024 Exploring the association between androgenetic alopecia and alcohol consumption BUSAN, South Korea, Nov. 27, 2024 /PRNewswire/ -- Androgenetic alopecia (AGA) is the most common form of hair ...
Read MorePR Newswire TORONTO, Nov. 27, 2024 In this free webinar, learn about the role of apheresis in sourcing high-quality starting materials for cellular therapies like CAR T-cell treatments and stem cell transplants. Attendees will gain insights ...
Read MorePR Newswire TORONTO, Nov. 27, 2024 In this free webinar, learn about the fundamentals and applications of RNA technologies. Attendees will learn how self-amplifying RNA (saRNA) is advancing vaccine and gene therapy development. The featured ...
Read MoreSubscribe to our Free Newsletters!